GAMMA Investing’s MaxCyte MXCT Stock Holding History

GAMMA Investing’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$6.39K	Hold	5,702	–	–	﹤0.01%	3554
2026 Q2	$7.01K	Buy	5,702 +269	+5%	+$268	﹤0.01%	3349
2026 Q1	$3.82K	Buy	+5,433	New	+$5.07K	﹤0.01%	3469

Other funds holding MXCT

KWMG LLC Overland Park, Kansas $1.39B AUM 24.28% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's MXCT Position: Q3 2026 in Review

GAMMA Investing held its MaxCyte (MXCT) position steady in Q3 2026 at 5,702 shares worth $6.39K. The position accounts for ﹤0.01% of the portfolio, ranked #3554.

GAMMA Investing first reported a position in MXCT in Q1 2026 and has held it in 3 quarters since. The position peaked at $7.01K in Q2 2026. 3 funds tracked by Wall St. Rank hold MXCT as of Q3 2026.

GAMMA Investing held 5,702 shares of MaxCyte worth $6.39K as of Q3 2026.
GAMMA Investing left its MaxCyte share count unchanged in Q3 2026.
MaxCyte made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3554 holding.
GAMMA Investing first reported a position in MaxCyte in Q1 2026 and has held it in 3 quarters since.
GAMMA Investing's MaxCyte position peaked at $7.01K in Q2 2026.
3 funds tracked by Wall St. Rank held MaxCyte as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.